Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HDL2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 190 | 192 | PF00675 | 0.431 |
CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.698 |
CLV_PCSK_KEX2_1 | 190 | 192 | PF00082 | 0.405 |
CLV_PCSK_KEX2_1 | 52 | 54 | PF00082 | 0.601 |
CLV_PCSK_PC1ET2_1 | 52 | 54 | PF00082 | 0.601 |
CLV_PCSK_SKI1_1 | 106 | 110 | PF00082 | 0.458 |
CLV_PCSK_SKI1_1 | 127 | 131 | PF00082 | 0.543 |
CLV_PCSK_SKI1_1 | 192 | 196 | PF00082 | 0.476 |
CLV_PCSK_SKI1_1 | 44 | 48 | PF00082 | 0.472 |
DEG_MDM2_SWIB_1 | 56 | 63 | PF02201 | 0.464 |
DEG_SPOP_SBC_1 | 121 | 125 | PF00917 | 0.288 |
DOC_MAPK_MEF2A_6 | 19 | 27 | PF00069 | 0.649 |
DOC_MAPK_MEF2A_6 | 205 | 212 | PF00069 | 0.490 |
DOC_PP1_RVXF_1 | 125 | 131 | PF00149 | 0.495 |
DOC_PP4_FxxP_1 | 232 | 235 | PF00568 | 0.507 |
DOC_USP7_MATH_1 | 8 | 12 | PF00917 | 0.668 |
DOC_USP7_UBL2_3 | 205 | 209 | PF12436 | 0.490 |
LIG_14-3-3_CanoR_1 | 19 | 23 | PF00244 | 0.409 |
LIG_14-3-3_CanoR_1 | 190 | 195 | PF00244 | 0.519 |
LIG_14-3-3_CanoR_1 | 53 | 57 | PF00244 | 0.564 |
LIG_AP2alpha_1 | 228 | 232 | PF02296 | 0.545 |
LIG_APCC_ABBAyCdc20_2 | 191 | 197 | PF00400 | 0.403 |
LIG_BRCT_BRCA1_1 | 218 | 222 | PF00533 | 0.432 |
LIG_EH_1 | 74 | 78 | PF12763 | 0.607 |
LIG_FHA_1 | 121 | 127 | PF00498 | 0.503 |
LIG_FHA_1 | 153 | 159 | PF00498 | 0.555 |
LIG_FHA_1 | 169 | 175 | PF00498 | 0.491 |
LIG_FHA_1 | 247 | 253 | PF00498 | 0.597 |
LIG_FHA_2 | 142 | 148 | PF00498 | 0.511 |
LIG_FHA_2 | 160 | 166 | PF00498 | 0.563 |
LIG_FHA_2 | 222 | 228 | PF00498 | 0.381 |
LIG_LIR_Apic_2 | 230 | 235 | PF02991 | 0.589 |
LIG_LIR_Gen_1 | 57 | 67 | PF02991 | 0.564 |
LIG_LIR_Gen_1 | 95 | 101 | PF02991 | 0.442 |
LIG_LIR_Nem_3 | 219 | 225 | PF02991 | 0.407 |
LIG_LIR_Nem_3 | 57 | 63 | PF02991 | 0.572 |
LIG_LIR_Nem_3 | 92 | 96 | PF02991 | 0.411 |
LIG_MYND_1 | 204 | 208 | PF01753 | 0.428 |
LIG_NRBOX | 42 | 48 | PF00104 | 0.292 |
LIG_Pex14_2 | 228 | 232 | PF04695 | 0.518 |
LIG_Pex14_2 | 56 | 60 | PF04695 | 0.531 |
LIG_SH2_NCK_1 | 35 | 39 | PF00017 | 0.607 |
LIG_SH2_STAP1 | 35 | 39 | PF00017 | 0.575 |
LIG_SH2_STAT3 | 39 | 42 | PF00017 | 0.328 |
LIG_SH2_STAT3 | 96 | 99 | PF00017 | 0.495 |
LIG_SH2_STAT5 | 107 | 110 | PF00017 | 0.359 |
LIG_SH2_STAT5 | 216 | 219 | PF00017 | 0.404 |
LIG_SH2_STAT5 | 96 | 99 | PF00017 | 0.407 |
LIG_SH3_3 | 198 | 204 | PF00018 | 0.498 |
LIG_SH3_3 | 245 | 251 | PF00018 | 0.497 |
LIG_SUMO_SIM_anti_2 | 141 | 147 | PF11976 | 0.442 |
LIG_SUMO_SIM_anti_2 | 21 | 27 | PF11976 | 0.432 |
LIG_SUMO_SIM_par_1 | 175 | 182 | PF11976 | 0.509 |
LIG_WRC_WIRS_1 | 229 | 234 | PF05994 | 0.310 |
LIG_WW_3 | 1 | 5 | PF00397 | 0.726 |
MOD_CK1_1 | 141 | 147 | PF00069 | 0.471 |
MOD_CK1_1 | 152 | 158 | PF00069 | 0.312 |
MOD_CK1_1 | 182 | 188 | PF00069 | 0.384 |
MOD_CK1_1 | 193 | 199 | PF00069 | 0.535 |
MOD_CK1_1 | 221 | 227 | PF00069 | 0.544 |
MOD_CK1_1 | 81 | 87 | PF00069 | 0.590 |
MOD_CK2_1 | 159 | 165 | PF00069 | 0.534 |
MOD_CK2_1 | 173 | 179 | PF00069 | 0.524 |
MOD_CK2_1 | 221 | 227 | PF00069 | 0.392 |
MOD_CK2_1 | 8 | 14 | PF00069 | 0.619 |
MOD_Cter_Amidation | 188 | 191 | PF01082 | 0.375 |
MOD_Cter_Amidation | 48 | 51 | PF01082 | 0.421 |
MOD_GlcNHglycan | 10 | 13 | PF01048 | 0.517 |
MOD_GlcNHglycan | 140 | 143 | PF01048 | 0.498 |
MOD_GSK3_1 | 14 | 21 | PF00069 | 0.541 |
MOD_GSK3_1 | 168 | 175 | PF00069 | 0.528 |
MOD_GSK3_1 | 179 | 186 | PF00069 | 0.428 |
MOD_GSK3_1 | 81 | 88 | PF00069 | 0.525 |
MOD_NEK2_1 | 228 | 233 | PF00069 | 0.456 |
MOD_NEK2_1 | 78 | 83 | PF00069 | 0.528 |
MOD_PIKK_1 | 179 | 185 | PF00454 | 0.452 |
MOD_PIKK_1 | 78 | 84 | PF00454 | 0.661 |
MOD_PK_1 | 190 | 196 | PF00069 | 0.562 |
MOD_PKA_1 | 190 | 196 | PF00069 | 0.559 |
MOD_PKA_1 | 51 | 57 | PF00069 | 0.571 |
MOD_PKA_2 | 18 | 24 | PF00069 | 0.625 |
MOD_PKA_2 | 190 | 196 | PF00069 | 0.428 |
MOD_PKA_2 | 52 | 58 | PF00069 | 0.567 |
MOD_Plk_1 | 121 | 127 | PF00069 | 0.279 |
MOD_Plk_1 | 159 | 165 | PF00069 | 0.599 |
MOD_Plk_1 | 172 | 178 | PF00069 | 0.511 |
MOD_Plk_2-3 | 173 | 179 | PF00069 | 0.379 |
MOD_Plk_2-3 | 18 | 24 | PF00069 | 0.566 |
MOD_Plk_4 | 173 | 179 | PF00069 | 0.524 |
MOD_Plk_4 | 18 | 24 | PF00069 | 0.514 |
MOD_Plk_4 | 190 | 196 | PF00069 | 0.395 |
MOD_Plk_4 | 218 | 224 | PF00069 | 0.538 |
MOD_Plk_4 | 85 | 91 | PF00069 | 0.489 |
MOD_SUMO_for_1 | 208 | 211 | PF00179 | 0.485 |
MOD_SUMO_rev_2 | 113 | 118 | PF00179 | 0.529 |
MOD_SUMO_rev_2 | 61 | 69 | PF00179 | 0.572 |
TRG_NLS_MonoCore_2 | 49 | 54 | PF00514 | 0.570 |
TRG_NLS_MonoExtN_4 | 50 | 55 | PF00514 | 0.589 |
TRG_Pf-PMV_PEXEL_1 | 127 | 132 | PF00026 | 0.531 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IHY5 | Leptomonas seymouri | 53% | 100% |
A0A0S4J677 | Bodo saltans | 24% | 77% |
A0A0S4JEV4 | Bodo saltans | 24% | 77% |
A0A1X0NX29 | Trypanosomatidae | 33% | 96% |
A0A3S7WYF1 | Leishmania donovani | 79% | 100% |
A4I0W9 | Leishmania infantum | 79% | 100% |
C9ZWH8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 96% |
E9AWX3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 100% |
Q4QAK1 | Leishmania major | 81% | 100% |
V5BAW4 | Trypanosoma cruzi | 36% | 81% |